- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01128036
Comparison of Different Locations for Pulse Oximetry Probes in Cardiovascular (CV) Patients With Poor Peripheral Perfusion
August 8, 2011 updated by: Saint Luke's Health System
Comparison of Different Locations for Pulse Oximetry Probes in Adult Cardiovascular Patients With Poor Peripheral Perfusion
The purpose of this study is to determine if the forehand location for sensor placement has less episodes of signal dropout than the finger sensor location.
In addition, this study will evaluate two finger sensors, which utilize different technology to compare signal quality.
Study Overview
Status
Terminated
Conditions
Detailed Description
A comparison study design will be used to evaluate the signal quality of pulse oximetry sensors placed in two locations: forehand and finger.
Each subject will serve as their own control, with measurements of signal quality evaluated at 2 second intervals over a period of one hour.
The measurements will be recorded simultaneously with a computer program and laptop computer.
Finger and forehand sensors will be applied according to manufacturer's guidelines.
An output connection will be made from each pulse oximeter computer unit to a password protected, laptop computer for data downloading.
Data will be collected for a 1 hour period at 2 second increments and stored in the hard drive of the laptop.
Following completion of data collection, the study sensors will be removed.
Study Type
Observational
Enrollment (Actual)
51
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Missouri
-
Kansas City, Missouri, United States, 64111
- Saint Luke's Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients admitted to the CICU (Coronary Intensive Coronary Unit) with congestive heart failure or cardiomyopathy
Description
Inclusion Criteria:
- CICU patients with a new diagnosis or history of CHF or cardiomyopathy
- Patients with a medical order for pulse oximetry monitoring
- Age greater than or equal to 18 years of age
- English speaking
- Signs of hypoperfusion
Exclusion Criteria:
- CICU patients with an impediment to sensor application
- CICU patients with excessive facial edema
- CICU patients with mechanical ventilation
- CICU patients with intra-aortic balloon pump therapy
- CICU patients with intravenous vasopressor drug administration
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
CHF, cardomyopathy
Patients with signs of poor peripheral perfusion due to cardiomyopathy or congestive heart failure
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Signal quality loss (dropout rate)
Time Frame: Every 2 seconds for one hour
|
Every 2 seconds for one hour
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Study Director: Lisa Riggs, MSN, Saint Luke's Hospital
- Principal Investigator: Marci Sportsman, BSN, Saint Luke's Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2010
Primary Completion (Actual)
May 1, 2011
Study Completion (Actual)
May 1, 2011
Study Registration Dates
First Submitted
May 20, 2010
First Submitted That Met QC Criteria
May 20, 2010
First Posted (Estimate)
May 21, 2010
Study Record Updates
Last Update Posted (Estimate)
August 9, 2011
Last Update Submitted That Met QC Criteria
August 8, 2011
Last Verified
August 1, 2011
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- COVMOPO0054
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Congestive Heart Failure
-
Echosense Ltd.WithdrawnCongestive Heart Failure (CHF)United States
-
Corthera, Inc.(formerly BAS Medical, Inc.), a member...TerminatedCongestive Heart Failure (CHF)Russian Federation
-
Meir Medical CenterUnknown
-
Adnan Kastrati, MDBiotronik SE & Co. KGCompleted
-
Signature Medical, Inc.WithdrawnHeart Failure,Congestive
-
Nihon KohdenTerminatedHeart Failure,CongestiveUnited States
-
ELA Medical, Inc.Approved for marketing
-
Abbott Medical DevicesCompletedCongestive Heart Failure TreatedItaly
-
Echosense Ltd.Terminated
-
Magenta Medical Ltd.TerminatedCongestive Heart Failure | Heart Failure, Congestive | Acute Heart FailureCroatia, Belgium, Serbia